 |
|
 |
 |
 |
| Company Background |
Markets > Corporate Information > Company Background |
 |
|
|
| Rubicon Research Ltd |
Industry: Pharmaceuticals - Indian - Formulations |
|
|
| BSE Code |
ISIN Demat |
Book Value (R) |
NSE Symbol |
Div Yield % |
Market Cap (Rs.Cr) |
P/E (TTM) |
EPS (TTM) |
Face Value (R) |
| 544578 |
INE506V01022 |
76.3063838 |
RUBICON |
0 |
12,701.43 |
80.14 |
9.62 |
1 |
|
|
|
|
| Incorporation Year |
1999 |
| Registered Office |
Medone House B-75 Road No.33,Wagle Estate, Thane (West), Maharashtra-400604 |
| Telephone |
022 6141 4000 |
| Fax |
NA |
| Chairman |
K G Ananthakrishnan |
| Managing Director |
PRATIBHA SUDHIR PILGAONKAR |
| Company Secretary |
Deepashree Omkar Tanksale |
| Auditor |
Deloitte Haskins & Sells LLP |
| Face Value |
1 |
| Market Lot |
1 |
| Listing |
BSE,NSE |
| Registrar |
MUFG Intime India Pvt Ltd C-101 247 Park,L B S Marg,Vikhroli West,Mumbai-400083 |
|
|
|
|
|
 |
|
|
|
|
|
|
|